Aegis Wealth Management (Iowa)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
3,521
-18
-0.5% -$18.4K 2.73% 6
2026
Q1
$3.26M Buy
3,539
+23
+0.7% +$23.3K 2.56% 7
2025
Q4
$3.78M Buy
+3,516
New +$3.36M 2.97% 6

Other funds holding LLY

Aegis Wealth Management (Iowa)'s LLY Position: Q2 2026 in Review

Aegis Wealth Management (Iowa) reduced its Eli Lilly (LLY) stake by 0.51% in Q2 2026, selling an estimated $18.4K and leaving 3,521 shares worth $4.22M. The position accounts for 2.73% of the portfolio, ranked #6.

Aegis Wealth Management (Iowa) first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aegis Wealth Management (Iowa) held 3,521 shares of Eli Lilly worth $4.22M as of Q2 2026.
  • Aegis Wealth Management (Iowa) sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 2.73% of Aegis Wealth Management (Iowa)'s portfolio in Q2 2026, its #6 holding.
  • Aegis Wealth Management (Iowa) first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aegis Wealth Management (Iowa)'s 13F filing for Q2 2026, filed 16 Jul 2026.